Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel antibiotic effective against Clostridium difficile-associated diarrhea

Dec. 30, 2005

Wyeth and Progenics collaborate on development of methylnaltrexone

Dec. 29, 2005

ANA-975 to begin phase Ib study in chronic hepatitis C patients

Dec. 28, 2005

Japanese approval for expanded use of Peg-Intron and Rebetol in HCV

Dec. 27, 2005

Sirna selects Sirna-AV34 as development candidate for hepatitis C

Dec. 27, 2005

Fast track designation for VX-950 in hepatitis C

Dec. 23, 2005

Positive results of synDNA hepatitis B vaccine study

Dec. 22, 2005

BLX-1060 -- potential for IBD

Dec. 21, 2005

Pharmasset present data on their new anti-HCV agent

Dec. 19, 2005

Zadaxin and pegylated interferon alpha fail to demonstrate statistically significant benefit in HCV

Dec. 19, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...